Rezulin and Byetta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rezulin (troglitazone) and Byetta (exenatide synthetic). Common drug interactions include chronic kidney disease among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Rezulin and Byetta. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Rezulin?

Rezulin has active ingredients of troglitazone. eHealthMe is studying from 8,764 Rezulin users. Check the latest studies of Rezulin.

What is Byetta?

Byetta has active ingredients of exenatide synthetic. It is often used in diabetes. eHealthMe is studying from 60,818 Byetta users. Check the latest studies of Byetta.

On Jul, 16, 2026

16 people who take Rezulin and Byetta together, and have interactions are studied.

What are the common drug interactions of Rezulin and Byetta, by gender? *:

female:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Metrorrhagia (uterine bleeding at irregular intervals)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nephrogenic anaemia (anaemia due to kidney disease)
Nephropathy (damage to or disease of a kidney)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Vaginal haemorrhage (vaginal bleeding)

male:

Renal failure (kidney dysfunction)
Colon cancer
Kidney fibrosis (excess fibrous connective tissue in kidney)
Nephrosclerosis (hardening of the kidney due to renovascular disease)
Jaundice cholestatic
Metastases to liver (cancer spreads to liver)
Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
Pneumonia
Pulmonary embolism (blockage of the main artery of the lung)
Chronic kidney disease

What are the common drug interactions of Rezulin and Byetta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Renal failure (kidney dysfunction)
Kidney fibrosis (excess fibrous connective tissue in kidney)
Nephrosclerosis (hardening of the kidney due to renovascular disease)

40-49:

n/a

50-59:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Nephropathy (damage to or disease of a kidney)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)

60+:

Colon cancer
Jaundice cholestatic
Metrorrhagia (uterine bleeding at irregular intervals)
Vaginal haemorrhage (vaginal bleeding)
Metastases to liver (cancer spreads to liver)
Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
Pneumonia
Pulmonary embolism (blockage of the main artery of the lung)
Chronic kidney disease
Decreased appetite

What are the existing conditions these people have? *

Type 2 Diabetes: 11 people, 68.75%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 25.00%
High Blood Pressure: 4 people, 25.00%
Vitamin E Deficiency: 2 people, 12.50%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 12.50%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 12.50%
Cardiac Disorder: 2 people, 12.50%
Cardiac Failure Congestive: 2 people, 12.50%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 12.50%
Constipation: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Rezulin and Byetta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously